7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
      
    		                           
      cash flows from operating activities
    		                           
      net income
    		-33,347,000 -49,940,000 -43,843,000 -37,512,000 -23,673,000 -33,403,000 -32,286,000 -26,016,000 -21,879,000 -24,136,000 -30,213,000 -28,869,000 -25,831,000 -26,691,000 -28,392,000 -28,452,000 -30,211,000 -26,222,000 -25,935,000 -30,526,000 -28,816,000 -31,349,000 -37,793,000 -38,973,000 -22,252,000 -22,477,000 -21,444,000 
      adjustment to reconcile net income to net cash from operating activities:
    		                           
      depreciation and amortization
    		80,000 80,000 72,000 68,000 68,000 70,000 123,000 190,000 186,000 209,000 217,000 236,000 239,000 234,000 215,000 213,000 217,000 210,000 191,000 121,000 117,000 96,000 82,000 108,000 65,000 60,000 63,000 
      accrued financing on prepaid forward obligation
    		1,472,000 2,012,000 -1,889,000 6,064,000 3,074,000 3,340,000 2,599,000 2,790,000 2,732,000 3,109,000 2,873,000 2,988,000 2,660,000 4,070,000 4,289,000 6,265,000 6,253,000           
      accretion on marketable securities
    		-160,000 -866,000 -774,000                         
      share-based compensation
    		3,027,000 2,733,000 3,069,000 3,303,000 3,489,000 3,560,000 2,756,000 2,611,000 2,224,000 2,222,000 2,286,000 2,368,000 2,440,000 2,823,000 2,949,000 5,357,000            
      amortization (accretion) of discount on long-term debt
    		-397,000 400,000 374,000                         
      amortization of right of use assets
    		559,000 516,000 425,000  198,000 193,000 228,000  229,000 222,000 218,000 214,000 196,000               
      acquisitions of ipr&d
    		0 0 3,128,000                         
      changes in operating assets and liabilities:
    		                           
      inventory
    		-1,213,000 462,000 1,637,000 -1,633,000 -152,000 -199,000 -1,570,000 -671,000 -14,000 477,000 -1,140,000 283,000 -165,000 -556,000 76,000 -1,024,000 -387,000 -90,000 -1,367,000 -618,000        
      accounts receivable
    		-54,000 -11,000 664,000 2,500,000 -5,387,000 -3,257,000 1,285,000 -2,596,000 2,658,000 -3,012,000 211,000 -3,275,000 2,166,000 -2,096,000 2,218,000 -3,934,000 1,728,000 -3,211,000 746,000 -4,237,000        
      prepaid expenses and other current assets
    		-67,000 928,000 -4,138,000 5,208,000 -1,845,000 -1,717,000 -210,000 5,757,000 -3,315,000 -577,000 -1,045,000 -522,000 -146,000      -2,952,000 931,000        
      other non-current assets
    		-5,958,000 -430,000 218,000 -219,000 303,000 425,000 940,000 12,000 767,000 344,000 -421,000 -269,000 -556,000 -275,000 -169,000 553,000 -547,000           
      accounts payable and accrued expenses
    		-4,789,000 640,000 2,891,000 7,746,000 -4,069,000 5,596,000 1,620,000 2,455,000 -2,320,000 -727,000 4,747,000 3,027,000 708,000      535,000 1,261,000        
      employee related accrued expenses
    		-532,000 4,679,000 -3,603,000 1,541,000 2,180,000 1,864,000 -5,829,000 2,662,000 1,431,000 1,802,000 -3,338,000 1,632,000 197,000      -4,842,000 1,763,000        
      other current liabilities
    		-263,000 -421,000 483,000         1,000 0 -1,005,000 301,000 642,000 -790,000           
      lease liabilities
    		-628,000 -606,000 -738,000 -408,000 -184,000 -195,000 -247,000 -221,000 -262,000 -252,000 -252,000 -269,000 -282,000               
      restricted deposit
    		0   -1,000 0                       
      net cash from operating activities
    		-42,270,000 -39,825,000 -42,024,000 -13,619,000 -27,664,000 -23,748,000 -31,735,000 -12,996,000 -17,299,000 -20,274,000 -25,807,000 -21,752,000 -17,612,000 -24,199,000 -23,996,000 -20,070,000 -18,476,000 -18,945,000 -27,401,000 -21,242,000 -25,080,000 -23,929,000 -35,635,000 -26,000,000 -12,528,000 -14,555,000 -17,934,000 
      capex
    		-87,000 -141,000 -44,000 -115,000 -96,000 0 0 -56,000 -100,000 -15,000 -23,000 -13,000 -153,000 -63,000 -25,000 -202,000 -194,000 -69,000 -287,000 0 -660,000 -287,000 -96,000 0 -49,000 0 -44,000 
      free cash flows
    		-42,357,000 -39,966,000 -42,068,000 -13,734,000 -27,760,000 -23,748,000 -31,735,000 -13,052,000 -17,399,000 -20,289,000 -25,830,000 -21,765,000 -17,765,000 -24,262,000 -24,021,000 -20,272,000 -18,670,000 -19,014,000 -27,688,000 -21,242,000 -25,740,000 -24,216,000 -35,731,000 -26,000,000 -12,577,000 -14,555,000 -17,978,000 
      cash flows from investing activities
    		                           
      purchases of marketable securities
    		-8,721,000 -1,789,000 -66,351,000 -9,229,000    -14,823,000 -10,833,000 0 -24,176,000 0     -9,939,000           
      maturities of marketable securities
    		40,206,000 30,336,000 40,432,000 69,965,000 12,140,000 12,082,000 13,518,000 3,535,000 11,334,000 3,735,000 30,469,000 23,121,000 27,669,000 -88,000 13,621,000 9,631,000 18,330,000 10,984,000 15,311,000 49,638,000 13,893,000 38,111,000 22,499,000 38,490,000    
      purchases of property and equipment
    		-87,000 -141,000 -44,000 -115,000 -96,000   -56,000 -100,000 -15,000 -23,000 -13,000 -153,000 -63,000 -25,000 -202,000 -194,000 -69,000 -287,000  -660,000 -287,000 -96,000  -49,000   
      net cash from investing activities
    		31,398,000 28,406,000 -25,963,000 60,621,000 -106,750,000 11,998,000 13,518,000 -11,344,000 401,000 3,720,000 6,270,000 23,108,000 -35,493,000 -151,000 13,596,000 9,125,000 10,660,000 -30,740,000 15,024,000 49,465,000 13,234,000 17,514,000 13,025,000 9,296,000 -12,659,000 -142,186,000 -44,000 
      cash flows from financing activities
    		                           
      proceeds from exercise of options into ordinary shares
    		302,000 297,000 30,000 71,000 115,000   40,000 19,000 143,000 671,000 378,000 1,117,000   0 3,000 54,000 4,000 89,000 148,000 210,000 293,000 321,000 1,126,000 685,000 1,532,000 
      proceeds from issuance of long-term debt
    		           24,990,000 0 -38,000 70,831,000             
      proceeds from pre-funded warrant issuance, net of issuance costs
    		0   0 0                       
      proceeds from ordinary shares issuances, net of issuance costs
    		                           
      net cash from financing activities
    		8,272,000 296,000 34,000 71,000 39,606,000 100,285,000 54,657,000 40,000 116,077,000 143,000 671,000 25,368,000 1,101,000 -77,000 70,742,000 -32,000 -168,000 72,515,000 4,000 78,000 61,000 16,298,000 90,000 245,000 1,126,000 373,000 163,506,000 
      increase in cash and cash equivalents
    		-2,600,000 -11,123,000 -67,953,000 47,073,000 -94,808,000 88,535,000 36,440,000 -24,300,000 99,179,000 -16,411,000 -18,866,000 26,724,000 -52,004,000 -24,427,000 60,342,000 -10,977,000 -7,984,000     9,883,000 -22,520,000 -16,459,000 -24,061,000 -156,368,000 145,528,000 
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 173,062,000  0 0 95,822,000  0 0 56,220,000  1,000 -1,000 45,587,000  0 0 54,090,000         
      cash, cash equivalents and restricted cash at end of period
    		-2,600,000 -11,123,000 105,109,000  -94,808,000 88,535,000 132,262,000  99,179,000 -16,411,000 37,354,000  -52,003,000 -24,428,000 105,929,000  -7,984,000 22,830,000 41,717,000         
      supplemental disclosures of non-cash activities
    		                           
      right of use assets obtained in exchange for new operating lease liabilities
    		3,498,000 1,313,000 2,045,000      27,000 0 95,000 0                
      proceeds from ordinary shares issuance, net of issuance costs
    		  4,000 0                        
      amortization of right-of-use assets
    		                           
      uncertain tax positions
    		                           
      proceeds from issuance of long-term debt, net of issuance costs
    		                           
      cash, cash equivalents and restricted cash at beginning of year
    		                           
      cash, cash equivalents and restricted cash at end of year
    		                           
      right-of-use assets obtained in exchange for new operating lease liabilities
    		                           
      (accretion) on marketable securities
    		    -1,074,000 -298,000 -183,000 -412,000                    
      amortization of discount on long-term debt
    		    -592,000 223,000 -961,000  222,000 355,000 404,000 677,000                
      proceeds from ordinary share issuance, net of issuance costs
    		     81,509,000 54,657,000                     
      inventory obsolescence
    		           255,000 350,000               
      proceeds from pre-funded warrant issuance, net of 1,654 of issuance costs
    		       0                    
      proceeds from ordinary share issuance, net of 2,288 of issuance costs
    		       0                    
      issuance cost related to at-the-market issuances
    		           0 -16,000 -55,000 -89,000 -17,000 -116,000   -11,000        
      amortization (accretion) on marketable securities
    		         -310,000 -354,000 -405,000                
      non-cash issuance cost
    		              3,000            312,000 
      sales of marketable securities
    		               0            
      proceeds from prepaid forward arrangement
    		               -15,000 -55,000           
      amortization on marketable securities
    		             119,000 50,000 133,000 162,000 -10,000 191,000         
      interest expense on long-term debt
    		             121,000 282,000             
      non-cash new lease liabilities
    		             1,413,000 6,000  0 -16,000 -20,000  22,000 -43,000 72,000     
      amortization of right of use asset
    		              241,000 238,000 235,000 232,000 237,000 494,000 381,000 379,000 374,000     
      lease liability
    		              -286,000  -262,000 -252,000 -400,000 -384,000 -409,000 -387,000 -361,000  -246,000 -201,000 -173,000 
      prepaid expense and other current assets
    		              -1,800,000 -1,362,000 -805,000           
      accounts payable and accrued expense
    		              -2,169,000 966,000 713,000           
      employee related accrued expense
    		              -1,801,000 472,000 -297,000           
      purchase of marketable securities
    		                   -1,000 1,000 -20,310,000 -9,378,000 -28,834,000    
      issuances of ordinary shares, net of issuance expenses
    		                           
      purchase of property and equipment
    		                          -44,000 
      accrued issuance cost
    		                           
      new lease liabilities
    		                           
      issuances of ordinary shares, net of issuance expense
    		                           
      exercise of options
    		                         -513,000 515,000 
      stock-based compensation
    		                 6,046,000 6,195,000 6,526,000 6,763,000 7,119,000 7,617,000 8,065,000 7,243,000 7,212,000 7,447,000 
      non-cash purchases of property and equipment
    		                           
      decrease in cash and cash equivalents
    		                  -12,373,000 28,301,000        
      current tax payable
    		                           
      change in restricted deposit
    		                       -168,000 0   
      issuance of ordinary shares, net of issuance expenses
    		                   0 -32,000   0 0   
      issuance cost
    		                           
      cash flows from operating activities:
    		                           
      amortization/accretion on marketable securities
    		                    152,000 136,000 98,000 -75,000 -330,000   
      cash flows from investing activities:
    		                           
      cash flows from financing activities:
    		                           
      cash, cash equivalents and restricted cash at beginning of the period
    		                    0 0 50,211,000     
      cash, cash equivalents and restricted cash at end of the period
    		                    -11,785,000 9,883,000 27,691,000     
      supplemental disclosures of non-cash activities:
    		                           
      increase in inventory
    		                           
      increase in accounts receivable
    		                           
      increase in prepaid expenses and other current assets
    		                     -517,000 -518,000 126,000 562,000 -1,041,000 -41,000 
      decrease in accounts payable and accrued expenses
    		                     452,000 -2,498,000    -2,440,000 
      decrease in employee related accrued expenses
    		                     1,669,000 -2,636,000    -1,591,000 
      supplemental disclosures of non-cash investing and financing activities:
    		                           
      non-cash purchase of property and equipment
    		                           
      issuance cost for shelf filing
    		                      -203,000     
      fair value adjustment of warrants for preferred shares
    		                           
      realized loss on sale of short-term investment
    		                           
      change in lease liability
    		                           
      decrease (increase) in inventory
    		                           
      decrease in accounts receivable
    		                           
      increase in accounts payable and accrued expenses
    		                       3,118,000 809,000   
      increase in deferred revenues
    		                           
      increase in employee related accrued expenses
    		                       1,629,000 1,376,000   
      sale of short-term investments
    		                           
      proceeds from exercise of warrants for preferred shares
    		                           
      issuance cost for secondary offering
    		                           
      cash, cash equivalents and restricted cash at beginning of the year
    		                       0 0   
      cash, cash equivalents and restricted cash at end of the year
    		                       -16,459,000 -24,061,000 -156,368,000 247,099,000 
      exercise of warrants to preferred shares
    		                           
      exchange rate differences
    		                           
      right of use asset
    		                        245,000 246,000 245,000 
      decrease in inventory
    		                           
      decrease in deferred revenues
    		                           
      sale of short-term investment
    		                           
      short-term investments
    		                           
      issuance of ordinary shares, net of issurance expenses
    		                          161,974,000 
      cash, cash equivalents and restriced cash at beginning of the year
    		                          101,571,000 
      decrease (increase) in accounts receivable
    		                           
      decrease (increase) in prepaid expenses and other current assets
    		                           
      payment of deferred equity offering cost
    		                           
      adjustments required to reconcile net income to net cash from operating activities:
    		                           
      depreciation
    		                           
      in process r&d
    		                           
      share based compensation
    		                           
      exchange rates differences
    		                           
      changes in operating asset and liabilities:
    		                           
      proceeds from issuance of preferred shares from 2014 share purchase agreement net of issuance cost
    		                           
      balance of cash and cash equivalents at beginning of the year
    		                           
      balance of cash and cash equivalents at end of the year
    		                           
      purchase of ip r&d in consideration for preferred a shares
    		                           
      non cash issuance cost
    		                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.